Nilotinib Knilonat 150mg Capsules
Nilotinib Knilonat 150mg Capsules

Nilotinib Knilonat 150mg Capsules

MOQ : 10 Pieces

Nilotinib Knilonat 150mg Capsules Specification

  • Dosage Form
  • Capsules
  • Pacakaging (Quantity Per Box)
  • 30 capsules per box
  • Indication
  • Philadelphia chromosome positive Chronic Myeloid Leukemia (Ph+ CML)
  • Salt Composition
  • Nilotinib 150 mg
  • Brand Name
  • Knilonat
  • Packaging Type
  • Box
  • Life Span
  • Check expiry on packaging
  • Origin of Medicine
  • India
  • Drug Type
  • Antineoplastic (anticancer)
  • Ingredients
  • Nilotinib
  • Physical Form
  • Capsule
  • Function
  • Anticancer, used for the treatment of leukemia
  • Recommended For
  • Chronic Myeloid Leukemia (CML) patients
  • Dosage
  • 150 mg per capsule
  • Dosage Guidelines
  • As prescribed by the physician
  • Suitable For
  • Adults
  • Quantity
  • 30 capsules (3 x 10 capsules)
  • Storage Instructions
  • Store in a cool, dry place away from sunlight
  • Minimum Order Quantity
  • As per requirement or export regulations
  • Warnings and Precautions
  • To be used under medical supervision only
  • Therapeutic Class
  • Tyrosine kinase inhibitor
  • Prescription/Non-Prescription
  • Prescription
  • Administration Route
  • Oral
  • Product Code
  • Knilonat150mgCapsules
  • Side Effects
  • Consult physician for detailed side effects
  • Country of Export
  • Available for export in Canada, EU, UK, USA, Australia
 
 

Nilotinib Knilonat 150mg Capsules About



Discover the featured Knilonat 150mg Capsules, a top-rated oral antineoplastic solution for Chronic Myeloid Leukemia (CML). Manufactured in India with the ace ingredient Nilotinib, these magnificent capsules are approved for export to Canada, the EU, UK, USA, and Australia. Pick yours with confidence, knowing each box contains 30 capsules expertly formulated to target Philadelphia chromosome positive CML. For sensational results, use only under prescription and store securely as recommended. Consult your physician for side effects, warnings, and personalized dosage guidelines.

Surface Application, Directions, and Notable Features

Nilotinib Knilonat 150mg Capsules are designed for oral use, administered strictly as directed by your physician. This ace pharmaceutical offers targeted therapy for adults with Philadelphia chromosome positive Chronic Myeloid Leukemia. Each box contains 30 capsules, ensuring consistent delivery of the active agent Nilotinib. Store the medicine in a cool, dry place, shielded from sunlight to maintain its efficacy. The magnificent efficacy of Knilonat comes with detailed physician guidance for the best possible outcomes.


Sample Availability, Delivery Timelines, and Order Fulfillment

Order processing for Nilotinib Knilonat 150mg Capsules is streamlined, with the potential for sample availability upon request. Enjoy reliable transport services for exports to Canada, the EU, UK, USA, and Australia. Our efficient supply chain ensures fast delivery times and flexible order quantities as per export regulations. Benefit from competitive sale prices and seamless packaging standards-each box contains 30 carefully packed capsules, providing peace of mind with every sale.


FAQ's of Nilotinib Knilonat 150mg Capsules:


Q: How should Nilotinib Knilonat 150mg Capsules be stored after purchase?

A: These capsules should be kept in a cool, dry place away from sunlight to preserve their effectiveness. Always refer to the expiry date on the packaging.

Q: What is the primary medical indication for using Nilotinib Knilonat 150mg Capsules?

A: Nilotinib Knilonat 150mg Capsules are specifically indicated for adults diagnosed with Philadelphia chromosome positive Chronic Myeloid Leukemia (Ph+ CML).

Q: How can orders for Nilotinib Knilonat 150mg Capsules be processed and delivered internationally?

A: Orders are processed upon meeting export regulations and are delivered through trusted transport services to Canada, the EU, UK, USA, and Australia. Effective order handling ensures timely delivery.

Q: What is the process to obtain a sample of Nilotinib Knilonat 150mg Capsules?

A: Samples can be requested directly from the manufacturer, supplier, or trader, subject to export regulations and availability.

Q: What are the recommended usage guidelines for Nilotinib Knilonat 150mg Capsules?

A: These capsules must be used exactly as prescribed by a qualified physician. Dosage and duration of therapy are tailored to individual patient requirements.

Q: What are the potential side effects and precautions of this medication?

A: It is crucial to consult your physician for comprehensive information on possible side effects, warnings, and precautions associated with Nilotinib. Use only under medical supervision.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Oncology Medicine Category

Veenat Imatinib Capsules IP 100 mg

Veenat Imatinib Capsules IP 100 mg

Price 2500 INR / Strip

Minimum Order Quantity : 100 Strips

Salt Composition : Imatinib

Dosage Guidelines : As directed by physician

Physical Form : Other, Capsule

Indication : Leukemia, Cancer treatment

Geftinat Gefitinib 250 Mg

Geftinat Gefitinib 250 Mg

Price 5000 INR / Bottle

Minimum Order Quantity : 100 Bottles

Salt Composition : Gefitinib 250 mg

Dosage Guidelines : As per doctors prescription

Physical Form : Other, Tablet

Indication : Treatment of metastatic NSCLC

Abiraterone Acetate Bdron 500mg

Abiraterone Acetate Bdron 500mg

Price 6000 INR / Bottle

Minimum Order Quantity : 100 Bottles

Salt Composition : Abiraterone Acetate 500 mg

Dosage Guidelines : As prescribed by doctor

Physical Form : Other, Tablet

Indication : Metastatic prostate cancer

Gliotem Temozolomide 100mg capsule

Gliotem Temozolomide 100mg capsule

Minimum Order Quantity : 10 Pieces

Salt Composition : Temozolomide 100mg

Dosage Guidelines : Follow the instructions advised by the oncologist or healthcare provider

Physical Form : Other, Capsule

Indication : Malignant glioma, including glioblastoma multiforme and anaplastic astrocytoma



Back to top